神经肌肉医学和物理医学与康复专家在神经肌肉疾病多学科管理中的作用。
The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease.
作者信息
McDonald Craig M, Fowler William M
机构信息
Department of Physical Medicine and Rehabilitation, University of California Davis School of Medicine, 4860 Y Street, Suite 3850, Sacramento, CA 95817, USA.
出版信息
Phys Med Rehabil Clin N Am. 2012 Aug;23(3):475-93. doi: 10.1016/j.pmr.2012.06.010.
Abstract
The neuromuscular medicine and physiatry specialists are key health care providers who work cooperatively with a multidisciplinary team to provide coordinated care for individuals with neuromuscular diseases (NMDs). The director or coordinator of the team must be aware of the potential issues specific to NMDs and be able to access the interventions that are the foundations for proper care in NMD. Ultimate goals include maximizing health and functional capacities, performing medical monitoring and surveillance to inhibit and prevent complications, and promoting access and full integration into the community to optimize quality of life.
摘要
神经肌肉医学和物理医学与康复专家是关键的医疗保健提供者，他们与多学科团队合作，为患有神经肌肉疾病（NMD）的个体提供协调的护理。该团队的主任或协调员必须了解NMD特有的潜在问题，并能够采用作为NMD适当护理基础的干预措施。最终目标包括最大限度地提高健康水平和功能能力，进行医学监测和监督以抑制和预防并发症，以及促进融入社区并完全融入社区以优化生活质量。
相似文献
1
The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease.
Phys Med Rehabil Clin N Am. 2012 Aug;23(3):475-93. doi: 10.1016/j.pmr.2012.06.010.
2
Physical therapy evaluation and management in neuromuscular diseases.
Phys Med Rehabil Clin N Am. 2012 Aug;23(3):633-51. doi: 10.1016/j.pmr.2012.06.005.
3
[How to maintain the motor capacities in neuromuscular disorders or the art to prescribe physical exercises].
Rev Med Suisse. 2014 Apr 30;10(428):958-61.
4
Effects of scoliosis on respiratory muscle strength in patients with neuromuscular disorders.
Spine J. 2009 Dec;9(12):981-6. doi: 10.1016/j.spinee.2009.08.451. Epub 2009 Oct 9.
5
The value of respiratory muscle testing in children with neuromuscular disease.
Chest. 2015 Feb;147(2):552-559. doi: 10.1378/chest.14-0819.
6
Role of exercise in the assessment and management of neuromuscular disease in children.
Med Sci Sports Exerc. 1996 Apr;28(4):421-7. doi: 10.1097/00005768-199604000-00005.
7
Neuromuscular diseases: Diagnosis and management.
Orthop Traumatol Surg Res. 2018 Feb;104(1S):S89-S95. doi: 10.1016/j.otsr.2017.04.019. Epub 2017 Nov 28.
8
Respiratory muscle training in children and adults with neuromuscular disease.
Cochrane Database Syst Rev. 2019 Sep 5;9(9):CD011711. doi: 10.1002/14651858.CD011711.pub2.
9
Neuromuscular Disorders in Pediatric Respiratory Disease.
Clin Chest Med. 2024 Sep;45(3):729-747. doi: 10.1016/j.ccm.2024.02.021. Epub 2024 Apr 4.
10
Respiratory involvement in neuromuscular disorders.
Curr Opin Neurol. 2017 Oct;30(5):529-537. doi: 10.1097/WCO.0000000000000470.
引用本文的文献
1
Management of motor rehabilitation in individuals with muscular dystrophies. 1 Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019).
Acta Myol. 2021 Jun 30;40(2):72-87. doi: 10.36185/2532-1900-046. eCollection 2021 Jun.
2
Effects of lumbar lordosis increment on gait deteriorations in ambulant boys with Duchenne Muscular Dystrophy: A cross-sectional study.
Braz J Phys Ther. 2021 Nov-Dec;25(6):749-755. doi: 10.1016/j.bjpt.2021.05.001. Epub 2021 May 24.
3
Optimizing Bone Health in Duchenne Muscular Dystrophy.
Int J Endocrinol. 2015;2015:928385. doi: 10.1155/2015/928385. Epub 2015 Jun 1.
4
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.
Muscle Nerve. 2013 Sep;48(3):357-68. doi: 10.1002/mus.23905. Epub 2013 Jul 17.
本文引用的文献
1
Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences.
PLoS Curr. 2012 Jan 25;4:RRN1297. doi: 10.1371/currents.RRN1297.
2
Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy.
Physiother Res Int. 2012 Jun;17(2):101-9. doi: 10.1002/pri.520. Epub 2011 Sep 23.
3
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
Lancet. 2011 Aug 13;378(9791):595-605. doi: 10.1016/S0140-6736(11)60756-3. Epub 2011 Jul 23.
4
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.
Neurology. 2011 Jul 19;77(3):250-6. doi: 10.1212/WNL.0b013e318225ab2e. Epub 2011 Jul 6.
5
Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.
Dev Med Child Neurol. 2011 Jun;53(6):535-42. doi: 10.1111/j.1469-8749.2011.03939.x. Epub 2011 Mar 17.
6
The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations.
Muscle Nerve. 2010 Dec;42(6):966-74. doi: 10.1002/mus.21808.
7
North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.
Neuromuscul Disord. 2010 Nov;20(11):712-6. doi: 10.1016/j.nmd.2010.06.014. Epub 2010 Jul 14.
8
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.
Lancet Neurol. 2010 Feb;9(2):177-89. doi: 10.1016/S1474-4422(09)70272-8. Epub 2009 Nov 27.
9
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.
Lancet Neurol. 2010 Jan;9(1):77-93. doi: 10.1016/S1474-4422(09)70271-6. Epub 2009 Nov 27.
10
The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
Muscle Nerve. 2010 Apr;41(4):500-10. doi: 10.1002/mus.21544.
Zotero 插件